Immuron New U.S. Department of Defense Award & Clinical Trial Update

Highlights: New US Department of Defense award to develop two new oral therapeutics targeting Campylobacter and ShigellaUniformed Services University P2TD clinical study update MELBOURNE, Australia, ...